22157.jpg
Circulating Tumor Cells Global Market Report 2023: Widespread Adoption of CTC-Based Liquid Biopsy Boosts Growth
March 08, 2023 06:03 ET | Research and Markets
Dublin, March 08, 2023 (GLOBE NEWSWIRE) -- The "Circulating Tumor Cells Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
U.S. Biopsy Market
United States Biopsy Market Report 2023: Sector to Reach $21.4 Billion by 2028 at a CAGR of 4.5%
March 03, 2023 09:13 ET | Research and Markets
Dublin, March 03, 2023 (GLOBE NEWSWIRE) -- The "United States Biopsy Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has been...
22157.jpg
World Liquid Biopsy Market Report 2023-2027: Market Share Assessments, Competitive Research, and Due Diligence for M&As
March 03, 2023 06:18 ET | Research and Markets
Dublin, March 03, 2023 (GLOBE NEWSWIRE) -- The "The World Market for Liquid Biopsy, 2023" report has been added to ResearchAndMarkets.com's offering. The World Liquid Biopsy Market, 2023,...
Predicine.png
Predicine to Present Four Studies at 2023 ASCO Genitourinary (GU) Symposium Highlighting the Technical and Clinical Utility of Predicine’s Liquid Biopsy Based Assays
February 16, 2023 16:05 ET | Predicine
HAYWARD, Calif., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Predicine, a global molecular insights company, is committed to advancing genitourinary (GU) cancer detection and treatment decisions through its...
22157.jpg
Europe Biomarker Technologies Market Research Report 2022: Focus on Immunoassay, DDPCR, Next Generation Sequencing (NGS), Mass Spectrometry, DHPLC - Trends, Forecasts & Opportunities to 2028
February 09, 2023 11:58 ET | Research and Markets
Dublin, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The "Europe Biomarker Technologies Market, By Test Type, By Technology (Immunoassay, DDPCR, Next Generation Sequencing (NGS), Mass Spectrometry, DHPLC,...
Global Market for Circulating Tumor Cell (CTC) Diagnostics
The Worldwide Circulating Tumor Cell (CTC) Diagnostics Industry is Projected to Reach $21.3 Billion by 2030: Increasing Research Reveal Further Complexities to CTC Composition and Behavior
February 09, 2023 10:28 ET | Research and Markets
Dublin, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The "Circulating Tumor Cell (CTC) Diagnostics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global...
22157.jpg
Global Liquid Biopsy Markets Report 2023: Cancer, Usage, Biomarker, Place, & Products Analysis with Price and Volume Outlook to 2027
February 08, 2023 09:18 ET | Research and Markets
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook. Including Executive and Consultant Guides and...
Global Liquid Biopsy Market
Global Liquid Biopsy Market Report 2022-2028: Competitive Developments, Strategies, Mergers, and Acquisitions, and New Biomarker Developments
February 02, 2023 04:58 ET | Research and Markets
Dublin, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The "Global Liquid Biopsy Market - Analysis by Biomarker Type (CTCs, ctDNA, EVs, Others), Product (Assay Kits, Instruments and Devices, Services), By...
22157.jpg
Global Clinical In-Vitro Diagnostic Medical Laboratory Services Market Report 2023: Genetic Based Testing Creates New Department and New Discipline
January 13, 2023 04:48 ET | Research and Markets
Dublin, Jan. 13, 2023 (GLOBE NEWSWIRE) -- The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry,...
logo-alt.png
Liquid Biopsy Market is estimated to be US$ 7.92 billion by 2030 with a CAGR of 19.8% during the forecast period - By PMI
January 09, 2023 10:02 ET | PMI
Covina, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Global Liquid Biopsy Market accounted for US$ 1.32 billion in 2020 and is estimated to be US$ 7.92 billion by 2030 and is anticipated to register a CAGR of...